SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Coherent (COHR) : Anyone else holding?
COHR 160.99+1.9%10:55 AM EST

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Thomas J Pittman who wrote (157)9/6/1997 9:51:00 PM
From: Thomas J Pittman   of 788
 
An update from Standard and Poors

In the September 3 issue, COHR is listed as one of
a number of 'quality' stocks that are underfollowed
by analysts.

More interestingly, comments on stock as a part of the
Master List pointed out that the recent operating
earnings increase of 17% and revenue increase of 15%
occurred despite the strengthening dollar and despite
more than 50% of sales coming from overseas. I had
missed this point. Given that even mighty Intel has
complained about weakness overseas, this is, to me,
a sign of true strength. The increase in order backlog
was pointed out as was the low debt and increasing
profit margin.

I am somewhat surprised at the recent drift in the
share price, but I am ever more persuaded that this
company has a bright future and that the stock will
follow suit.

Thanks for listening and for comments.

J
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext